Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways

American Journal of Physiology - Cell Physiology

Volumn 283, Issue 5 52-5, 2002, Pages

  Wang, Hong ^a   Ubl, Joachim J ^a   Stricker, Rolf ^a   Reiser, Georg ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Calcium signaling; Epidermal growth factor receptor; Extracellular signal regulated protein kinase; Mitogen activated protein kinase; Protease activated receptors; Transactivation

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; CALCIUM ION; EPIDERMAL GROWTH FACTOR RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HEPARIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 3; PROTEINASE ACTIVATED RECEPTOR 4; THROMBIN; TYROSINE; WORTMANNIN;

ARTICLE; ASTROCYTE; BINDING SITE; BRAIN CELL; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME MECHANISM; ENZYME PHOSPHORYLATION; ENZYME REGULATION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MITOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN INDUCTION; PROTEIN LOCALIZATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; TRANSACTIVATION;

RICKETTSIA SP. PAR;

EID: 0036838021     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00001.2002     Document Type: Article

References (65)

1. Alessi DR, Cuenda A, Cohen P, Dudley DT, and Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 270:27489-27494, 1995.
2. Banes A, Florian JA, and Watts SW. Mechanisms of 5-hydroxytryptamine(2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle. J Pharmacol Exp Ther 291: 1179-1187, 1999.
3. Berridge MJ, Bootman MD, and Lipp P. Calcium - a life and death signal. Nature 395: 645-648, 1998.
4. Bhat NR, Zhang P, and Hogan EL. Thrombin activates mitogen-activated protein kinase in primary astrocyte cultures. J Cell Physiol 165: 417-424, 1995.
5. Coughlin SR. Protease-activated receptors start a family. Proc Natl Acad Sci USA 91: 9200-9202, 1994.
6. Crouch MF, Davy DA, Willard FS, and Berven LA. Activation of endogenous thrombin receptors causes clustering and sensitization of epidermal growth factor receptors of Swiss 3T3 cells without transactivation. J Cell Biol 152: 263-273, 2001.
7. i oscillations in single rat glioma cells induced by thrombin through activation of cell surface receptors. Neuroreport 6: 1249-1252, 1995.
8. Daub H, Wallasch C, Lankenau A, Herrlich A, and Ullrich A. Signal characteristics of G protein-transactivated EGF receptor. EMBO J 16: 7032-7044, 1997.
9. Daub H, Weiss FU, Wallasch C, and Ullrich A. Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors. Nature 379: 557-560, 1996.
10. Debeir T, Gueugnon J, Vige X, and Benavides J. Transduction mechanisms involved in thrombin receptor-induced nerve growth factor secretion and cell division in primary cultures of astrocytes. J Neurochem 66: 2320-2328, 1996.
11. q-mediated pathways on calcium/calmodulin, Pyk2, and Src kinase. J Biol Chem 272: 19125-19132, 1997.
12. Dikic I and Blaukat A. Protein tyrosine kinase-mediated pathways in G protein-coupled receptor signaling. Cell Biochem Biophys 30: 369-387, 1999.
13. Ehrenreich H, Costa T, Clouse KA, Pluta RM, Ogino Y, Coligan JE, and Burd PR. Thrombin is a regulator of astrocytic endothelin-1. Brain Res 600: 201-207, 1993.
14. i-linked Ras/mitogen-activated protein kinase pathway. J Biol Chem 274: 13718-13727, 1999.
15. Fantl WJ, Johnson DE, and Williams LT. Signalling by receptor tyrosine kinases. Annu Rev Biochem 62: 453-481, 1993.
16. Feng DM, Veber DF, Connolly TM, Condra C, Tang MJ, and Nutt RF. Development of a potent thrombin receptor ligand. J Med Chem 38: 4125-4130, 1995.
17. Fry DW, Kraker AJ, McMichael A, Ambroso LA, Nelson JM, Leopold WR, Connors RW, and Bridges AJ. A specific inhibitor of the epidermal growth factor receptor tyrosine kinase. Science 265: 1093-1095, 1994.
18. Grabham P and Cunningham DD. Thrombin receptor activation stimulates astrocyte proliferation and reversal of stellation by distinct pathways: involvement of tyrosine phosphorylation. J Neurochem 64: 583-591, 1995.
19. Grand RJ, Turnell AS, and Grabham PW. Cellular consequences of thrombin-receptor activation. Biochem J 313: 353-368, 1996.
20. Graness A, Hanke S, Boehmer FD, Presek P, and Liebmann C. Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells. Biochem J 347: 441-447, 2000.
21. Gschwind A, Zwick E, Prenzel N, Leserer M, and Ullrich A. Cell communication networks: epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 20: 1594-1600, 2001.
22. Hawes BE, Luttrell LM, van Biesen T, and Lefkowitz RJ. Phosphatidylinositol 3-kinase is an early intermediate in the Gβτ-mediated mitogen-activated protein kinase signaling pathway. J Biol Chem 271: 12133-12136, 1996.
23. q-mediated mitogen-activated protein kinase activation. J Biol Chem 270: 17148-17153, 1995.
24. i proteins use a novel βτ- and Ras-independent pathway to activate extracellular signal-regulated kinase and mobilize AP-1 transcription factors in Jurkat T lymphocytes. J Biol Chem 274: 19992-20001, 1999.
25. Hsuan JJ, Downward J, Clark S, and Waterfield MD. Proteolytic generation of constitutive tyrosine kinase activity of the human insulin receptor. Biochem J 259: 519-527, 1989.
26. Ishihara H, Connolly AJ, Zeng D, Kahn ML, Zheng YW, Timmons C, Tram T, and Coughlin SR. Protease-activated receptor 3 is a second thrombin receptor in humans. Nature 386: 502-506, 1997.
27. Kalmes A, Vesti BR, Daum G, Abraham JA, and Clowes AW. Heparin blockade of thrombin-induced smooth muscle cell migration involves inhibition of epidermal growth factor (EGF) receptor transactivation by heparin-binding EGF-like growth factor. Circ Res 87: 92-98, 2000.
28. Kawabata A, Saifeddine M, Al Ani B, Leblond L, and Hollenberg MD. Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of PAR2 by PARl-targeted ligands. J Pharmacol Exp Ther 288: 358-370, 1999.
29. Kifor O, MacLeod RJ, Diaz R, Bai M, Yamaguchi T, Yao T, Kifor I, and Brown EM. Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. Am J Physiol Renal Physiol 280: F291-F302, 2001.
30. Kramer HK, Onoprishvili I, Andria ML, Hanna K, Sheinkman K, Haddad LB, and Simon EJ. Delta opioid activation of the mitogen-activated protein kinase cascade does not require transphosphorylation of receptor tyrosine kinases. BMC Pharmacol 2: 5, 2002.
31. i-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc. EMBO J 16: 3097-3105, 1997.
32. Krymskaya VP, Penn RB, Orsini MJ, Scott PH, Plevin RJ, Walker TR, Eszterhas AJ, Amrani Y, Chilvers ER, and Panettieri RA Jr. Phosphatidylinositol 3-kinase mediates mitogen-induced human airway smooth muscle cell proliferation. Am J Physiol Lung Cell Mol Physiol 277: L65-L78, 1999.
33. i2. J Cell Biol 121: 91-99, 1993.
34. Lerner DJ, Chen M, Tram T, and Coughlin SR. Agonist recognition by proteinase-activated receptor 2 and thrombin receptor. Importance of extracellular loop interactions for receptor function. J Biol Chem 271: 13943-13947, 1996.
35. Levitzki A and Gazit A. Tyrosine kinase inhibition: an approach to drug development. Science 267: 1782-1788, 1995.
36. Lin CC, Shyr MH, Chien CS, Wang CC, Chiu CT, Hsiao LD, and Yang CM. Mechanisms of thrombin-induced MAPK activation associated with cell proliferation in human cultured tracheal smooth muscle cells. Cell Signal 13: 257-267, 2001.
37. 2+ channels. Science 287: 1647-1651, 2000.
38. Macfarlane SR, Seatter MJ, Kanke T, Hunter GD, and Plevin R. Proteinase-activated receptors. Pharmacol Rev 53: 245-282, 2001.
39. Marshall CJ. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179-185, 1995.
40. Martinez-Salgado C, Rodriguez-Barbero A, Tavares P, Eleno N, and Lopez -Novoa JM. Role of calcium in gentamicin-induced mesangial cell activation. Cell Physiol Biochem 10: 65-72, 2000.
41. Muthalif MM, Benter IF, Karzoun N, Fatima S, Harper J, Uddin MR, and Malik KU. 20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. Proc Natl Acad Sci USA 95: 12701-12706, 1998.
42. Osherov N and Levitzki A. Epidermal-growth-factor-dependent activation of the src-family kinases. Eur J Biochem 225: 1047-1053, 1994.
43. i2-mediated activation of the MAP kinase cascade. Mol Biol Cell 6: 1685-1695, 1995.
44. Panettieri RA Jr, Hall IP, Maki CS, and Murray RK. α-Thrombin increases cytosolic calcium and induces human airway smooth muscle cell proliferation. Am J Respir Cell Mol Biol 13: 205-216, 1995.
45. Pierce KL, Luttrell LM, and Lefkowitz RJ. New mechanisms in heptahelical receptor signaling to mitogen activated protein kinase cascades. Oncogene 20: 1532-1539, 2001.
46. Prenzel N, Zwick E, Daub H, Leserer M, Abraham R, Wallasch C, and Ullrich A. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF. Nature 402: 884-888, 2000.
47. 1 receptor in DDT(1)MF-2 cells. Br J Pharmacol 133: 1378-1386, 2001.
48. Rocic P, Govindarajan G, Sabri A, and Lucchesi PA. A role for PYK2 in regulation of ERK1/2 MAP kinases and PI 3-kinase by ANG II in vascular smooth muscle. Am J Physiol Cell Physiol 280: C90-C99, 2001.
49. Rojas M, Yao S, and Lin YZ. Controlling epidermal growth factor (EGF)-stimulated Ras activation in intact cells by a cell-permeable peptide mimicking phosphorylated EGF receptor. J Biol Chem 271: 27456-27461, 1996.
50. Schinkmann KA, Kim TA, and Avraham S. Glutamate-stimulated activation of DNA synthesis via mitogen-activated protein kinase in primary astrocytes: involvement of protein kinase C and related adhesion focal tyrosine kinase. J Neurochem 74: 1931-1940, 2000.
51. Kip1 expression in the vasculature of hypertensive rats. Circ Res 89: 488-495, 2001.
52. Stanimirovic DB, Ball R, Mealing G, Morley P, and Durkin JP. The role of intracellular calcium and protein kinase C in endothelin-stimulated proliferation of rat type I astrocytes. Glia 15: 119-130, 1995.
53. Striggow F, Riek M, Breder J, Henrich Noack P, Reymann KG, and Reiser G. The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc Natl Acad Sci USA 97: 2264-2269, 2000.
54. Striggow F, Riek-Burchardt M, Kiesel A, Schmidt W, Henrich-Noack P, Breder J, Krug M, Reymann KG, and. Reiser G. Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia. Eur J Neurosci 14: 595-608, 2001.
55. Sugawara H, Kurosaki M, Takata M, and Kurosaki T. Genetic evidence for involvement of type 1, type 2 and type 3 inositol 1,4,5-trisphosphate receptors in signal transduction through the B-cell antigen receptor. EMBO J 16: 3078-3088, 1997.
56. Trejo J, Connolly AJ, and Coughlin SR. The cloned thrombin receptor is necessary and sufficient for activation of mitogen-activated protein kinase and mitogenesis in mouse lung fibroblasts. Loss of responses in fibroblasts from receptor - knockout mice. J Biol Chem 271: 21536-21541, 1996.
57. i oscillations in rat glioma cells. Pflügers Arch 433: 312-320, 1997.
58. Ubl JJ and Reiser G. Characteristics of thrombin-induced calcium signals in rat astrocytes. Glia 21: 361-369, 1997.
59. i-inducing protease-activated receptors (PAR-1 and PAR-2) in rat astrocytes and C6 glioma cells. Neuroscience 86: 597-609, 1998.
60. Ushio-Fukai M, Griendling KK, Becker PL, Hilenski L, Halleran S, and Alexander RW. Epidermal growth factor receptor transactivation by angiotensin II requires reactive oxygen species in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21: 489-495, 2001.
61. ras. by G protein-coupled receptor agonists in fibroblasts. Proc Natl Acad Sci USA 90: 1257-1261, 1993.
62. Wang H, Ubl JJ, and Reiser G. The four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling. Glia 37: 53-63, 2002.
63. Xi G, Keep RF, Hua Y, Xiang J, and Hoff JT. Attenuation of thrombin-induced brain edema by cerebral thrombin preconditioning. Stroke 30: 1247-1255, 1999.
64. 3 blockade of endothelial cells. Mol Pharmacol 59: 1333-1342, 2001.
65. Zwick E, Hackel PO, Prenzel N, and Ullrich A. The EGF receptor as central transducer of heterologous signalling systems. Trends Pharmacol Sci 20: 408-412, 1999.